The impact of immunohistochemical markers of Ki-67 and p53 on the long-term outcome of growth hormone-secreting pituitary adenomas: A cohort study

Maysam Alimohamadi; Vahid Ownagh; Leila Mahouzi; Afshin Ostovar; Kazem Abbassioun; Abbas Amirjmshidi

doi:10.4103/1793-5482.142732

An Official publication of The Asian Congress of Neurological Surgeons (AsianCNS)

Users Online: 389

ORIGINAL ARTICLE

Year : 2014 | Volume : 9 | Issue : 3 | Page : 130-136

The impact of immunohistochemical markers of Ki-67 and p53 on the long-term outcome of growth hormone-secreting pituitary adenomas: A cohort study

Maysam Alimohamadi¹, Vahid Ownagh², Leila Mahouzi³, Afshin Ostovar⁴, Kazem Abbassioun⁵, Abbas Amirjmshidi⁶
¹ Department of Neurosurgery, Tehran University of Medical Sciences, Tehran, Iran
² Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran
³ Arad Hospital, Tehran University of Medical Sciences, Tehran, Iran
⁴ The Persian Gulf Infectious Diseases and Tropical Medicine Research Center, Bushehr University of Medical Sciences, Bushehr, Iran
⁵ Department of Neurosurgery, Arad Hospital, Tehran University of Medical Sciences, Tehran, Iran
⁶ Department of Neurosurgery, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran

Correspondence Address:
Prof. Abbas Amirjmshidi
Sina Hospital, Tehran University of Medical Sciences, Tehran
Iran

Source of Support: None, Conflict of Interest: None

Check

DOI: 10.4103/1793-5482.142732

Background and Objectives: The tumoral biomarkers have a rather well known effect upon the tumor control period of several types of malignant lesions. The aim of this study was to evaluate the impact of immunohistochemical (IHC) markers of Ki-67 and p53 on the long-term outcome of growth hormone (GH)-secreting pituitary adenomas treated surgically. Materials and Methods: We conducted and followed a cohort of 47 consecutive patients with GH-secreting pituitary adenomas referred to our department during a 4 year period for trans-sphenoidal microsurgical adenomectomy. The expression levels of Ki-67 and p53 were determined by IHC study of the tissue samples. Periodical pituitary magnetic resonance imaging (MRI), visual field studies and hormonal evaluations (GH and insulin-like growth factor-1 [IGF-1]) performed during the follow-up period were the outcome measures. Results: The level of Ki-67 expression was higher among patients with postoperative residual tumor (3.5 vs. 1.7%) and those with a hormonal recurrence (4.3 vs. 1.6%). The p53 expression level was remarkably higher in patients with radiological recurrence (18 vs. 6.3%). Patients with invasive features (i.e. cavernous sinus and suprasellar invasion) had significantly higher p53 and Ki-67 values and higher IGF-1 levels during the follow-up period. The patients younger than 30 years of age and those with mixed GH-prolactin secreting adenomas had significantly higher hormonal remission and lower radiological recurrence rates. Conclusion: Each of the biomarkers, Ki-67 and p53, along with patient's age and mixed GH-prolactin secretion showed a kind of correlation with each of aspects of the clinical, hormonal and radiologic outcome of GH-secreting pituitary adenomas in this series.

[FULL TEXT] [PDF]*

Table of Contents

Similar in PUBMED

Search Pubmed for

Search in Google Scholar for

Related articles

Citation Manager

Access Statistics

Reader Comments

Email Alert *

Add to My List *

* Requires registration (Free)

Article Access Statistics

Viewed	2923

Printed	38

Emailed	0

PDF Downloaded	531

Comments	[Add]

Cited by others	12